Mechanisms of Action of Combination Motivational Interviewing-Cognitive
Behavior Therapy for Reversing Medication Non-adherence in Patients with
Multiple Sclerosis
Abstract
Objective: Despite disease modifying therapies’ (DMT) demonstrated
efficacy for treating relapsing MS, around 40% of patients discontinue
use. This study aimed to understand the mechanism of action of
Motivational Interviewing plus cognitive behavioral therapy (MI-CBT) in
a previously conducted randomized controlled trial in which the MI-CBT
intervention successfully promoted DMT re-initiation of participants
compared to a treatment as usual (TAU) condition. Method: This secondary
analysis (N=91) explored changes in motivation (a single item motivation
“ruler” [Mot ∆], and the Brief Motivation Scale [BMS∆]),
autonomous motivation (AR∆), personal control (PC∆), treatment control
(TC∆), and confidence to re-initiate (Con∆) as potential mediators of
the treatment effect, using logistic regression. Results: Logistic
regression analysis including all potential mediators as predictors of
initiation indicated the BMS∆ was the only statistically significant
predictor (OR = 1.61, p = .010). When BMS∆ was removed Mot∆ (OR = 1.22
, p = .002) and PC∆ (OR = 1.67, p = .002) were
statistically significant predictors of initiation. The MI-CBT
intervention appeared to work primarily by increasing motivation to
initiate DMT.